Solutions
5 parts of one journey.
The chain
Every stage is where a different problem hides
A funnel that reports only the first step and the last one cannot tell you which of these you have.
Patient journey
Source held throughout
What happens here
Someone searches for the treatment, finds a listing, or is referred by a patient you already have.
Where it leaks
Nothing records which of those it was, so every later number is unattributable.
Patient acquisition
Grow demand
Visibility, content and campaigns pointed at the procedures the practice wants to grow, measured by the treatment they produce rather than the leads they generate.
When it is not this: If your chairs are full and your problem is scheduling rather than demand, more leads will make the week worse. Start with follow-up and conversion instead.
Patient acquisition in detail →Follow-up & conversion
Convert demand
A marketing report will never show it, because by its own measure the lead arrived and the job was done. RevSource Dental puts response, follow-up and conversion inside the model, and uses Wysera's AI to answer faster, follow up more consistently, and move more opportunities toward treatment.
When it is not this: If inquiries are already answered within the hour and follow-up is owned by a named person, this is not your bottleneck. Demand, or procedure mix, probably is.
Follow-up & conversion in detail →Revenue attribution
Prove value
Most practices can see the first step and the last one, and very little in between. RevSource Dental is designed to preserve patient source through the treatment journey, giving the practice a clearer view of which acquisition efforts produce appointments, treatment starts, and revenue.
When it is not this: This measures patient acquisition. It is not a practice management system, it does not replace your PMS, and it does not do clinical charting.
Revenue attribution in detail →Treatment revenue insights
Grow the right procedures
Attribution answers where patients came from. Treatment revenue insights answer what they became: which procedures are presented, accepted, started and collected, and where the practice has room to grow the ones that matter most.
When it is not this: This is not a replacement for your practice management system or your accounting. It reads the patient journey around acquisition, not the full clinical and financial record.
Treatment revenue insights in detail →DentalPrice patient demand
High-intent demand
DentalPrice reaches people who are looking up dental treatment and its cost before they choose a practice, and adds that demand where a practice has capacity to grow.
When it is not this: If a practice has no room for more of a procedure, demand for it creates a waiting list, not growth. The recommendation then is follow-up and conversion first, or nothing at all.
DentalPrice patient demand in detail →Supporting capabilities
Useful around the core, not the core itself
What makes it different
Context and economics, not a better algorithm.
What we are against is fragmented patient acquisition with no economic accountability. Not a practice's current agency, CRM or website partner. Keep what produces value, and replace something only when the evidence says so.
- Practice-specific, not generic
- Starts with clinical priorities, economics, market, capacity, patient objections and what makes the practice different, rather than a template applied to every office.
- Treatment-focused, not activity-focused
- Measures outcomes that matter to the business: qualified opportunities, appointments, treatment starts and revenue.
- Marketing plus demand
- Wysera supports the growth activity while DentalPrice contributes a separate stream of patients already researching care. Two different jobs, not one restated.
- Acquisition plus conversion
- A lead that never gets called back is a marketing problem the marketing report will never show. Follow-up is inside the model.
- Acquisition tied to collected revenue
- The north star is connecting patient acquisition investment as closely as possible to collected treatment revenue.
Want to look at where your patient acquisition dollars are going today?
If there is an opportunity worth testing, we will find it in that conversation. If there is not, that is a useful answer too.